Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Preveceutical Medical Inc C.PREV

Alternate Symbol(s):  PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its BSV peptide program targets cancer progression. Its Non-Addictive Analgesic is an engineering non-addictive analgesic peptide for pain management. Its Dual Gene Therapy targets type 2 diabetes and obesity. The Company’s subsidiary, PreveCeutical (Australia) Pty Ltd., manages its research programs.


CSE:PREV - Post by User

Bullboard Posts
Post by Ravenelon Dec 04, 2018 10:02am
134 Views
Post# 29060244

Found this: What Can Investors Expect

Found this: What Can Investors Expect

What can investors expect from the BCSC investigation?

The first hearing is dated next Friday, December 7. The companies will remain under temporary block until then, and the hearing will determine if the block needs to be extended. In the meantime, the investigation is anticipated to continue. It is within the right of the BCSC to continue their investigation up to and past the date of the official hearing, which has yet to be announced.

Once the date of that hearing is announced, each company will have their opportunity to present their cases to the panel of BCSC commissioners. The panel then has ninety days to issue their findings. If found guilty, the companies can have their security shares restricted, suspended, or canceled. There are also fines of up to $1 million per transgression, and guilty parties can be held responsible for any legal or administrative fees accrued during the investigation.

https://www.potnetwork.com/news/bcsc-alleges-fraud-so-called-cannabis-consulting-firm

Bullboard Posts